Why EverydayMeds Offers The UK's Best Value For Both Treatments
Understanding Mounjaro And Wegovy Doses For UK Patients
When comparing Mounjaro and Wegovy doses, it's essential to understand that these are two distinct prescription-only medicines with different mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that works on a single pathway to reduce appetite and promote satiety. Mounjaro contains tirzepatide, which uniquely targets both GIP and GLP-1 receptors as a dual agonist, potentially offering enhanced metabolic benefits through this dual mechanism.
The dosing schedules for both treatments follow carefully structured escalation protocols designed to minimise side effects whilst maximising therapeutic benefits. Wegovy doses progress from 0.25mg weekly through to the maintenance dose of 2.4mg, with each step lasting four weeks. Mounjaro follows a similar graduated approach but with different dose strengths and timings. Both medications must be prescribed alongside a reduced-calorie diet and increased physical activity for optimal results.
Competitive Pricing For Mounjaro And Wegovy Doses In The UK
EverydayMeds offers some of the UK's most competitive pricing for both Mounjaro and Wegovy doses, with transparent costs that include consultation, prescription, and medication delivery. Wegovy prices start at £79.99 for the initial 0.25mg starter dose, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our discount codes FIRST40 for new customers and DOSE25 for returning patients are applied at checkout to reach these final prices.
For added convenience, we offer carefully curated bundles such as the Intro Duo (0.25mg and 0.5mg Wegovy for £169.99) and Progress Trio combinations that provide multiple months of treatment in a single order. Mounjaro pricing remains equally competitive through our GPhC-registered pharmacy (#9012878), ensuring patients can access either treatment without compromising on quality or affordability. Our bundling options provide convenience rather than savings, offering Reliable Supply continuity and reducing the need for frequent reorders.
Clinical Evidence Supporting Mounjaro And Wegovy Doses
The clinical evidence supporting both Mounjaro and Wegovy doses comes from extensive phase 3 trials involving thousands of participants. In clinical trials, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks in the STEP 1 trial (Wilding et al., NEJM, 2021), compared to 2.4% with placebo. The STEP programme demonstrated consistent efficacy across different patient populations, including those with type 2 diabetes.
Mounjaro's clinical trials showed its dual GIP/GLP-1 mechanism may offer additional metabolic benefits, though direct head-to-head comparisons between the treatments use different trial designs and patient populations. Both medications have been rigorously tested and approved by the MHRA for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities, when used as part of a comprehensive weight management programme.
How Wegovy Doses Work In Your Body
Wegovy's active ingredient, semaglutide, works as a GLP-1 receptor agonist that mimics a natural hormone produced in your intestines when you eat. This mechanism helps regulate appetite by sending signals to your brain's appetite control centres, potentially reducing food cravings and promoting feelings of fullness after smaller meals. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety. Unlike rapid-acting appetite suppressants, Wegovy's effects build gradually as doses are escalated, allowing your body to adapt whilst maintaining therapeutic benefits. The once-weekly injection schedule using the convenient FlexTouch pen makes adherence easier compared to daily medications.
Streamlined Ordering Process For Mounjaro And Wegovy Doses
Accessing either Mounjaro or Wegovy doses through EverydayMeds involves a straightforward three-step process designed for maximum convenience and clinical safety. The journey begins with a comprehensive 3-minute online clinical assessment that evaluates your medical history, current medications, and weight management goals to determine suitability for either treatment. Our qualified prescribers then review your assessment, typically within 3 working days (or 24 hours with express review), to determine the most appropriate medication and starting dose for your individual circumstances. Once approved, your prescription-only medicine is dispatched via next-day cold-chain delivery, maintaining the strict temperature requirements essential for these biological medications. Our GPhC-registered pharmacy (#9012878) ensures every step meets UK regulatory standards for patient safety and medication quality.
Storage Requirements For Mounjaro And Wegovy Doses
Proper storage of both Mounjaro and Wegovy doses is crucial for maintaining medication effectiveness and ensuring patient safety throughout treatment. Both medications must be stored in the refrigerator at 2-8°C before first use, protected from light and never frozen. Wegovy offers a significant practical advantage for UK patients who travel frequently, as unopened pens can be kept at room temperature (below 30°C) for up to 6 weeks, compared to Mounjaro's 21-day room temperature limit. Once you begin using either pen, it can typically be stored at room temperature for the duration of that pen's use, making daily administration more convenient. The FlexTouch pen design used for Wegovy and similar pen injectors for Mounjaro are engineered for ease of use, with clear dose windows and simple injection mechanisms suitable for self-administration.
Choosing Between Mounjaro And Wegovy Doses Based On UK Availability
The decision between Mounjaro and Wegovy doses often comes down to individual patient factors, prescriber recommendations, and practical considerations like cost and availability. Wegovy's longer room temperature stability makes it ideal for frequent travellers, whilst Mounjaro's dual-agonist mechanism may appeal to patients seeking the latest therapeutic innovation. Both treatments require the same commitment to lifestyle modifications and regular monitoring.
Pricing considerations also play a role, as Wegovy's established UK presence often translates to more predictable supply chains and competitive pricing structures. EverydayMeds stocks both treatments to ensure patients have options, and our clinical team can provide guidance on which medication aligns best with individual circumstances. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which is right for you.
Start Your Weight Management Journey With Mounjaro And Wegovy Doses
Beginning treatment with either Mounjaro or Wegovy doses represents a significant step towards effective weight management, backed by robust clinical evidence and MHRA approval. Our transparent pricing structure, starting from £79.99 for Wegovy's initial dose, removes financial barriers whilst maintaining the highest standards of clinical care through our registered pharmacy services. Apply discount code FIRST40 as a new customer or DOSE25 if returning at checkout to access these competitive prices, with next-day delivery ensuring you can start your treatment journey without delay. Visit https://everydaymeds.co.uk/collections/wegovy to complete your clinical assessment and discover which treatment option best suits your individual needs. Whether you choose Mounjaro or Wegovy doses, our experienced clinical team supports your weight management goals every step of the way.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
